← Travere Therapeutics, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $41.0m | $99.4m | $102.9m | $62.4m | $84.8m | $165.8m | $61.7m | $58.2m | $58.5m | $93.0m | |
| Prepaid Expense and Other Assets, Current | $4.8m | $3.1m | $2.3m | $5.0m | $8.1m | $6.5m | $12.6m | $19.3m | $12.7m | $28.8m | |
| Inventory, Net | $2.8m | $5.4m | $5.6m | $6.1m | $7.6m | $7.3m | $6.9m | $9.4m | $6.2m | $36.2m | |
| Assets, Current | $332.4m | $325.8m | $495.7m | $429.1m | $410.4m | $582.8m | $486.4m | $616.8m | $416.7m | $437.6m | |
| Property, Plant and Equipment, Net | $2.6m | $3.2m | $3.1m | $2.9m | $9.4m | $11.1m | $9.0m | $7.5m | $5.3m | $4.0m | |
| Goodwill | $936k | $936k | $936k | $936k | $936k | $900k | $900k | $800k | $800k | — | |
| Intangible Assets, Net (Excluding Goodwill) | $182.0m | $184.8m | $186.7m | $157.2m | $153.2m | $148.4m | $145.0m | $104.4m | $104.0m | $113.9m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $7.0m | $25.7m | $23.2m | $21.0m | $18.1m | $14.3m | $10.6m | |
| Other Assets, Noncurrent | $7.4m | $5.6m | $7.7m | $14.7m | $33.5m | $11.1m | $11.1m | $10.7m | $18.2m | $8.9m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $18.5m | $13.9m | $14.5m | $18.0m | $15.9m | $15.9m | $16.6m | $21.2m | $27.1m | $80.1m | |
| Accrued Liabilities, Current | $33.3m | $36.0m | $49.7m | $51.7m | $56.8m | $75.2m | $95.7m | $119.0m | $86.0m | $126.0m | |
| Assets | $525.3m | $520.3m | $709.2m | $604.8m | $607.4m | $776.6m | $672.6m | $788.9m | $594.1m | $605.2m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $2.6m | $357k | $3.9m | $4.4m | $4.9m | $5.4m | $5.9m | |
| Accounts Payable, Current | $7.5m | $18.9m | $7.0m | $26.6m | $12.1m | $15.1m | $17.3m | $41.7m | $23.5m | $24.8m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $7.4m | $28.3m | $31.5m | $27.5m | $22.6m | $17.2m | $11.1m | |
| Liabilities, Current | $83.3m | $85.7m | $104.6m | $95.4m | $92.7m | $124.1m | $142.2m | $177.9m | $200.8m | $159.9m | |
| Deferred Income Tax Liabilities, Net | — | $0 | — | — | — | — | — | — | — | — | |
| Other Liabilities, Noncurrent | $4.0m | $2.5m | $4.5m | $20.9m | $40.5m | $12.3m | $9.4m | $8.5m | $6.8m | $7.6m | |
| Deferred Tax Liabilities, Net | $6.4m | $0 | $0 | — | — | — | — | — | — | — | |
| Liabilities | $217.5m | $227.2m | $390.9m | $383.6m | $396.2m | $474.5m | $629.7m | $588.1m | $535.0m | $490.4m | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $4k | $4k | $4k | $4k | $5k | $6k | $6k | $7k | $9k | $9k | |
| Additional Paid in Capital | $421.3m | $471.8m | $589.8m | $636.9m | $798.0m | $1.1b | $1.1b | $1.3b | $1.5b | $1.6b | |
| Retained Earnings (Accumulated Deficit) | ($113.1m) | ($177.7m) | ($270.0m) | ($416.4m) | ($585.9m) | ($766.0m) | ($1.0b) | ($1.1b) | ($1.4b) | ($1.5b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($490k) | ($1.0m) | ($1.5m) | $726k | ($902k) | ($562k) | ($2.9m) | ($1.5m) | ($80k) | ($1.2m) | |
| Stockholders' Equity Attributable to Parent | $307.8m | $293.1m | $318.3m | $221.2m | $211.2m | $302.1m | $42.9m | $200.8m | $59.1m | $114.8m | |
| Liabilities and Equity | $525.3m | $520.3m | $709.2m | $604.8m | $607.4m | $776.6m | $672.6m | $788.9m | $594.1m | $605.2m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.